Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations

Z Miklja, A Pasternak, S Stallard, T Nicolaides… - Neuro …, 2019 - academic.oup.com
As the field of neuro-oncology makes headway in uncovering the key oncogenic drivers in
pediatric glioma, the role of precision diagnostics and therapies continues to rapidly evolve …

[HTML][HTML] Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

S Venneti, AR Kawakibi, S Ji, SM Waszak, SR Sweha… - Cancer discovery, 2023 - AACR
Abstract Patients with H3K27M-mutant diffuse midline glioma (DMG) have no proven
effective therapies. ONC201 has recently demonstrated efficacy in these patients, but the …

Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA

TD Azad, MC Jin, LJ Bernhardt, C Bettegowda - Neurosurgical focus, 2020 - thejns.org
Diffuse midline glioma (DMG) is a highly malignant childhood tumor with an exceedingly
poor prognosis and limited treatment options. The majority of these tumors harbor somatic …

Electronic DNA analysis of CSF cell-free tumor DNA to quantify multi-gene molecular response in pediatric high-grade glioma

AK Bruzek, K Ravi, A Muruganand, J Wadden… - Clinical Cancer …, 2020 - AACR
Purpose: Pediatric high-grade glioma (pHGG) diagnosis portends poor prognosis and
therapeutic monitoring remains difficult. Tumors release cell-free tumor DNA (cf-tDNA) into …

Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients

E Izquierdo, P Proszek, G Pericoli… - Neuro-oncology …, 2021 - academic.oup.com
Background The use of liquid biopsy is of potential high importance for children with high
grade (HGG) and diffuse midline gliomas (DMG), particularly where surgical procedures are …

[HTML][HTML] Liquid biopsy in pediatric brain tumors

A Tripathy, V John, J Wadden, S Kong, S Sharba… - Frontiers in …, 2023 - frontiersin.org
Malignant primary brain tumors are the most common cancer in children aged 0–14 years,
and are the most common cause of death among pediatric cancer patients. Compared to …

Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors

JA Lake, AM Donson, E Prince, KD Davies… - Pediatric blood & …, 2020 - Wiley Online Library
Background The use of next‐generation sequencing for fusion identification is being
increasingly applied and aids our understanding of tumor biology. Some fusions are …

[HTML][HTML] The clinical applications of liquid biopsies in pediatric brain tumors: a systematic literature review

L Greuter, N Frank, R Guzman, J Soleman - Cancers, 2022 - mdpi.com
Simple Summary Brain tumors are the most common solid cancer in children and are
traditionally diagnosed via a tissue biopsy or resection. Liquid biopsy offers the possibility to …

[HTML][HTML] An unusual association of deletion of SMARCB1 in a patient with intracranial yolk sac tumor: A case-report

A Gupte, E Al-Antary, K Regling, WJ Kupsky… - Pediatric Hematology …, 2024 - Elsevier
Background Deletion of SMARCB1/loss of INI is a well-known association in atypical
rhabdoid teratoid tumors (ATRT) in the brain, rhabdoid tumors in the kidney, and less …

Molecular alterations of low-grade gliomas in young patients: Strategies and platforms for routine evaluation

I Dandapath, R Chakraborty, K Kaur… - Neuro-Oncology …, 2021 - academic.oup.com
In recent years, it has been established that molecular biology of pediatric low-grade
gliomas (PLGGs) is entirely distinct from adults. The majority of the circumscribed pediatric …